Skip to main content
US EQUITIES AFTER-HOURS CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
MG

MGTXStockMeiraGTx Holdings plc

Nasdaq Global Select Market · Healthcare · US

$8.14 last close 2026-11-19
Open in terminalCompare
Price alert

Verdicts genuinely change. Free email alert the moment MGTX's does — no target price to set, unlike a price alert.

Sharia status
COMPLIANT
Per our secondary compliance provider · assessed 2026-08-25
0 of 3 pass our own screen — 4 of 7 could not be computed
HTR non-permissible income 2.23%
🕌Open research, not a fatwa — verify with your own scholar.

Trade setup

Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.

SEPARATE FROM SHARIAH
🔴 AVOID
The main driver: lagging the market by 9.4%, insider selling on the open market. Too many signals pointing the wrong...
Scores: 1 bullish / 3 bearish
59
of 100
Setup confidence — system conviction, not win probabilityC

Trade plan

Posted with a stop, a target and the level that invalidates it. It resolves into the public record either way.

PM_HIGH · SCALP
Entry
$11.26
Stop
$11.12
Target
$11.54
Risk : Reward 2.0R

Why this signal?

The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.

Structure0 of 5 timeframes bullish · 100.0% aligned
VWAPPrice below VWAP ($8.60)
VolumeRelative volume 4.3× the 20-day average
Momentum10-day rate of change +0.1%
Overall readAVOID

MeiraGTx Holdings plc (MGTX) is currently considered halal (Sharia-compliant), per our secondary compliance provider (last assessed 2026-08-25). See the full ratio breakdown and business-activity screen below for the reasoning.

This sits among 433 compliant Healthcare stocks we track. See compliant Healthcare stocks →

Market & analysts
Wall Street consensus
BUY
13 analysts
Institutional own.
70.4%
of shares
Momentum (10d)
+0.1%
rate of change
SMC grade
C · 59
100.0% aligned
2.23%
Non-permissible income — HTR, from filings (2025-12-31)
C · 59
SMC grade — 100.0% timeframe alignment
+0.1%
Rate of change (10d)
BUY
Wall Street consensus (13)
70.4%
Institutional ownership

🕌 In-house Compliance Research

Computed from published company financials, balance sheet as of 2026-09-30. These ratios come from the issuer's own published statements rather than structured SEC data.

AAOIFI divides by the market cap: $826.8M as of 2026-11-18. At the 2026-11-19 close it is about $832.7M (the stored market cap moved by the share price since, not a new share count), and at that cap AAOIFI's interest-bearing debt ratio would read 1.4% (1.4% at the stored cap, against a 30% line) and interest-bearing investments ratio would read 22.4% (22.6% at the stored cap, against a 30% line). The published verdict changes only when the company is re-screened.

Business activity: cleared (no excluded categories detected)

AAOIFI Unverified⚠️ debt implausibly low vs. real finance costs 3 of 3 ratios pass
RatioValueThresholdResult
Interest-bearing debt 1.43% 30.00% Pass(28.6pp buffer)
Interest-bearing investments 22.59% 30.00% Pass(7.4pp buffer)
Non-permissible income 2.23% 5.00% Pass(2.8pp buffer)
Usmani Fail 3 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 2.90% 33.00% Pass(30.1pp buffer)
Interest-bearing investments 45.36% 33.00% Fail(12.4pp over)
Non-liquid assets 54.64% at least 20.00% Pass(34.6pp above the floor)
Non-permissible income 2.23% 5.00% Pass(2.8pp buffer)
MSCI Fail 2 of 3 ratios pass
RatioValueThresholdResult
Interest-bearing debt 2.87% 33.33% Pass(30.5pp buffer)
Cash + interest-bearing securities 45.36% 33.33% Fail(12.0pp over)
Non-permissible income 2.23% 5.00% Pass(2.8pp buffer)
FTSE Fail 2 of 3 ratios pass
RatioValueThresholdResult
Interest-bearing debt 0.00% 33.33% Pass(33.3pp buffer)
Cash + interest-bearing securities 45.36% 33.33% Fail(12.0pp over)
Non-permissible income 2.23% 5.00% Pass(2.8pp buffer)
Dow Jones Islamic Market Unverified⚠️ a figure this standard divides by was not available, so it could not be scored — the rows below show what was and was not computed 3 of 3 ratios pass

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 1.41% 33.00% Pass(31.6pp buffer)
Cash + interest-bearing securities 22.31% 33.00% Pass(10.7pp buffer)
Non-permissible income 2.23% 5.00% Pass(2.8pp buffer)
S&P Shariah Unverified⚠️ a figure this standard divides by was not available, so it could not be scored — the rows below show what was and was not computed 3 of 3 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 1.71% 33.00% Pass(31.3pp buffer)
Cash + interest-bearing securities 26.91% 49.00% Pass(22.1pp buffer)
Non-permissible income 2.23% 5.00% Pass(2.8pp buffer)
MSCI M-Series Unverified⚠️ a figure this standard divides by was not available, so it could not be scored — the rows below show what was and was not computed 3 of 3 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 1.71% 33.33% Pass(31.6pp buffer)
Cash + interest-bearing securities 26.91% 33.33% Pass(6.4pp buffer)
Non-permissible income 2.23% 5.00% Pass(2.8pp buffer)

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

How close is it to flipping?

Every current reading against its own line, closest first. A verdict is only as durable as that distance.

Usmani (% of total assets)non permissible income ratio 2.8pts
MSCI Islamic Index (% of total assets)non permissible income ratio 2.8pts
FTSE Shariah Global Equity Index Series (% of total assets)non permissible income ratio 2.8pts
Usmani (% of total assets)investments ratio 12.4pts
MSCI Islamic Index (% of total assets)cash and interest ratio 12.0pts
FTSE Shariah Global Equity Index Series (% of total assets)cash and interest ratio 12.0pts

The numbers the ratios are built from

Read from MGTX's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.

LineFigureAs reportedRead from
RevenueTotal revenue for the period $81.4M 2025-12-31 Revenues
Interest-bearing debtShort and long-term borrowings $0 2026-09-30 no debt tag reported in 3+ years (treated as $0)
Cash and interest-bearing securitiesCash, equivalents and marketable securities $186.8M 2026-09-30 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
Total assetsBalance sheet total $411.7M 2026-09-30 Assets
Market capDenominator for AAOIFI $826.8M live quote price x shares
36-month average market capDenominator for S&P Shariah and MSCI M-Series $593.1M 756 trading days closes x shares
24-month average market capDenominator for Dow Jones Islamic Market $718.8M 504 trading days closes x shares
Non-permissible revenueInterest and excluded income $1.8M 2025-12-31 InvestmentIncomeInterest

Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.

Sources

Filing information. Balance sheet: Quarterly report (10-Q) filed 2026-11-12, period ended 2026-09-30. Income statement: Annual report (10-K) filed 2026-03-30, period ended 2025-12-31. Screened 2026-11-18.

  • Total assets$411.7M
    Assets · period ended 2026-09-30 · 10-Q filed 2026-11-12
  • Interest-bearing debt$0
    no debt tag reported in 3+ years (treated as $0) · balance sheet as of 2026-09-30 · no filing link for this figure
  • Cash and interest-bearing securities$186.8M
    CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · period ended 2026-09-30 · 10-Q filed 2026-11-12
  • Revenue$81.4M
    Revenues · period ended 2025-12-31 · 10-K filed 2026-03-30
  • Interest income (non-permissible)$1.8M
    InvestmentIncomeInterest · period ended 2025-12-31 · 10-K filed 2026-03-30
  • Market cap$826.8M
    Market quote passed in by the screen (Finnhub company profile; Yahoo Finance where Finnhub has none), 2026-11-18 · not a filing figure, so no link

4 reported values cited from 2 SEC filings, read from SEC's XBRL company facts when this symbol was screened. A link opens the filing's index on EDGAR.

What changed, and when

Verdict history for MGTX. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.

  • 2026-09-07 No change recorded No verdict change for MGTX has been recorded since tracking began. The scan ledger records that the compliance detectors ran, not which symbols each pass covered.

Tracked since 2026-09-07.

Shariah-compliant alternatives

Compliant companies in Biotechnology listed on the same market, largest first. Each is screened on its own; none carries a documented concern or a hold.

CompanyMarket capPrice, day
VRTXVertex Pharmaceuticals, Inc. $121.1B $520.66-2.94%
REGNRegeneron Pharmaceuticals, Inc. $85.3B —
ARGXArgen X SE - ADR $64.3B —
ONCBeOne Medicines Ltd. American Depositary Shares $40.4B —
ALNYAlnylam Pharmaceuticals Inc $31.6B —

A dash means no fresh quote is cached for that symbol; this list does not fetch one.

Funds that hold MGTX

3 of the 257 funds whose filed holdings we currently hold own MGTX shares. That set is a fixed list of widely held index funds and Shariah funds, plus the funds our look-through has read most recently. It is not every fund that owns MGTX.

Other funds
FundMGTX in fundFund compliant by weight
IWC iShares Micro-Cap ETF 0.17% 23%
JESIX Small Cap Index Trust 0.03% 31%
JAFFX Total Stock Market Index Trust 0.00% 52%

Sorted by MGTX’s share of each fund, from the fund’s latest SEC N-PORT filing. “Compliant by weight” is the share of the fund’s holdings our look-through screens compliant. A fund is listed only where its filing is mostly equity and names MGTX once, so a bond is not counted as the shares; 1 more fund name MGTX in a way we cannot separate from its bonds, and is not listed. Shariah funds are those with a recorded certification, on our halal ETF list, or named Shariah, Islamic, Halal or Sukuk.

14.9712.9810.988.986.992025-11-202026-05-222026-11-19

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
7.86
S2
8.08
S1
8.20
PIVOT
8.42
R1
8.54
R2
8.76
R3
8.88

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

7-day expected range
9.48 – 12.62
±14.23% from 11.05, made 2026-09-26 · resolves 2026-10-03
STRONG SELL
from 19 indicators
78.7% of our last 25417 forecasts — across every instrument we forecast, not just this one — landed inside their stated range, and 53.4% called the direction correctly.

Technical Summary

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

STRONG SELL
19 indicators
OscillatorsNEUTRAL
3 buy · 1 neutral · 3 sell
Moving averagesSTRONG SELL
0 buy · 0 neutral · 12 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)34.60NEUTRAL
Stochastic %K (14)3.39BUY
CCI (20)-172.65BUY
Williams %R (14)-96.61BUY
MACD (12,26,9)-0.04SELL
ROC (10)-4.35SELL
Momentum (10)-0.37SELL
EMA (10)8.78SELL
SMA (10)8.94SELL
EMA (20)9.15SELL
SMA (20)9.15SELL
EMA (30)9.52SELL
SMA (30)9.39SELL
EMA (50)10.12SELL
SMA (50)10.31SELL
EMA (100)10.67SELL
SMA (100)11.76SELL
EMA (200)9.94SELL
SMA (200)10.39SELL

About MeiraGTx Holdings plc

Healthcare · Biotechnology

MeiraGTx Holdings plc, a clinical-stage genetic medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases; neurodegenerative diseases; and xerostomia. It is also develops AAV-AQP1 for radiation-induced grade 2/3 radiation-induced xerostomia, as well as for Sjogren's syndrome; AAV-GAD in Phase 2 trial for Parkinson's disease; AAV-RPE65 in Phase 2 trial for RPE65-associated retinal dystrophy; and AAV-CNGB3 and AAV-CNGA3, which are both in Phase ½ clinical trial for achromatopsia, as well as offers AAV-AIPL1 for Leber congenital amaurosis (LCA) 4. In addition, the company's products under preclinical development include AAV-RDH12 for retinol dehydrogenase 12 mutation-associated retinal dystrophy; AAV-BBS10 for Bardet-Biedl syndrome (BBS) due to BBS10 mutations; AAV-RetGC for LCA type 1; and AAV-UPF1 for amyotrophic lateral sclerosis, as well as programs for Alzheimer's disease, and wet and dry neovascular age related macular degeneration. Further, it provides riboswitch platform for the delivery of metabolic peptides; and cell therapies for oncology, autoimmune disease, and long term intractable pain. The company has collaborations with Johnson & Johnson Innovative Medicine for the research, development, and commercialization of gene therapies for the treatment of inherited retinal disease; and Hologen Limited for the research, development, manufacture, and commercialization of AAV-GAD investigational gene therapy for the treatment of Parkinson's disease, AAV-BDNF investigational gene therapy for genetic obesity disorders, and other genetic medicines to the central nervous system. MeiraGTx Holdings plc was founded in 2015 and is based in New York, New York.

meiragtx.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

Latest Signal — 2026-09-30

PM HIGH
Type · SCALP
11.26
Entry
11.12
Stop
11.54
Target
LOSS
Outcome · exit 11.12 (-1.24%)

Stop 11.12 Now 8.14 Target 11.54

Verdict

🔴 AVOID

The main driver: lagging the market by 9.4%, insider selling on the open market. Too many signals pointing the wrong way. Wait for the picture to improve before committing capital.

Scores: 1 bullish / 3 bearish

Grade verdict

Average — needs more confirmation before sizing up

SMC — Top Down

Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.

TimeframeBiasBars
📅 Daily BEARISH 64
⏰ 4H BEARISH 38
🕐 1H BEARISH 98
⏱ 15-Min BEARISH 130
⏲ 5-Min BEARISH 234

Momentum & Volume

Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.

+0.1%
Rate of change (10d)
4.3×
Volume vs its 20-day average
-0.51
MACD (BEARISH)
$8.19
Volume POC (today)
$8.11 – $8.22
Value area

Peer Movement

How the rest of the sector moved over the same window. Context for a price move, never a cause of one.

Peer movement computing — it will appear here on its own.

Before you act on this

The questions worth asking about any verdict on this page, answered plainly.

Is this a fatwa?

No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.

Why can the standards disagree?

Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.

How often is this re-screened?

Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.

Do I need to purify dividends?

If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.

Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.

Compare with

Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.

Peer screening computing — it will appear here on its own.

Insider Activity (90d)

Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.

CLUSTER SELL   0 buys · 3 sells

Recent: Giroux Richard sold 908530 sh @ $12.51 (2026-07-21); Naylor Stuart sold 640846 sh @ $14.90 (2026-07-07); Naylor Stuart sold 665958 sh @ $13.86 (2026-07-07)

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.

NEUTRAL   report date 2026-11-10 · Asset managers net 914130 (-14454)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.